60 TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2026 For example, Tempus, a technology company, uses Al to analyze genomic data, enabling early detection of cancer and providing personalized treatment plans. The growing focus on early diagnosis is not only driven by the potential for better health outcomes but also by the need to reduce healthcare costs. Detecting diseases early can lead to more effective, less expensive treatments, preventing the need for costly interventions at later stages of the disease. Additionally, with aging populations and the increasing prevalence of chronic diseases globally, healthcare systems are under pressure to find solutions that improve efficiency and outcomes. Al tools meet this demand biv streamlining diagnostic processes, enhancing precision, and enabling healthcare providers to manage larger volumes of patients more effectively. Advanced technologies in the healthcare industry have resulted in the generation of intricate datasets crucial for Al applications. Big data analytics and Al have the potential to revolutionize healthcare processes, enhancing accuracy and efficiency. While these advancements offer transformative benefits, challenges such as data privacy, quality, and bias require vigilant attention to ensure ethical and equitable healthcare delivery. In healthcare, big data includes information generated from various sources such as medical devices, healthcare claims and billing records, and electronic health records. The increasing digitization and adoption of information systems in the healthcare industry are expected to increase the volume of big data in healthcare. Advanced Al tools are needed to comprehend vast amounts of unstructured health data. Government initiatives to accelerate Al innovations in healthcare will further boost market growth in the US. In October 2023, President Joe Biden signed an executive order aiming to establish standards for Al in healthcare. The National Science Foundation was tasked with initiatives to promote Al innovation, ensuring a skilled workforce to drive advancements in healthcare. The effective use of Al and machine learning algorithms can improve the response to disease outbreaks. The World Health Organization is focusing on early warnings of disease outbreaks, forecasting epidemics, and improved decisionmaking for healthcare professionals. Such initiatives are poised to drive the market growth. The global healthcare industry is facing significant cost pressures due to the increased demand for services, expensive prescription drugs, technological advancements, and a rise in chronic illnesses. Healthcare providers need to optimize their operations strategically by reallocating their resources, including staffing, medical devices, and operational dimensions. Adopting Al technologies can be a transformative driver in this optimization process. According to the Centre for Economic Policy Research, the widespread adoption of Al technology in healthcare could result in annual savings ranging from USD 200 to USD 360 billion over the next five years, constituting 5% to 10% of healthcare spending. This presents a significant financial benefit, along with the potential for quality enhancements, highlighting the pivotal role of Al in reducing healthcare costs and elevating the overall value of healthcare. Al-based tools can significantly reduce healthcare spending by minimizing manual labor and addressing inefficiencies in care delivery, overtreatment, and improper care. It streamlines operations and improves precision in resource allocation, thus contributing to a more efficient and cost-effective healthcare ecosystem. The Organisation for Economic Co-operation and Development (OECD) reported a post- pandemic decline in the average health expenditure to GDP ratio across member countries, reaching 9.2% in 2022 from 9.7% in 2021. However, 11 OECD nations surpassed the prepandemic level of 8.8%, and the US maintains the highest health expenditure to GDP ratio at 16.6%. This emphasizes the need for cost reduction in healthcare, and Al can play a crucial role in achieving it, aligning with the imperative to optimize healthcare expenditure globally. Recent advancements in supercomputing and Al have enabled the delivery of more precise and personalized healthcare services to patients. There is relevant evidence supporting the adoption of Al frameworks for reducing healthcare costs while maintaining or improving the quality of care. Albased tools for home healthcare can also minimize unnecessary hospital admissions, which, in turn, lower healthcare costs. The development of Al-based tools, such as GatorTronGPT, by the University of Florida and NVIDIA Corporation, highlights the potential for Al to support healthcare workers and reduce the workload on healthcare professionals. The GatorTronGPT model demonstrates the capability of Al to mimic human language for medical records, paving the way for applications that could replace the tedium of documentation. Therefore, Albased tools can result in potential savings for several end users in the healthcare industry, including patients, care providers, and healthcare payers. The demand for these tools is expected to increase significantly in the coming years. ARTIFICIAL INTELLIGENCE
RkJQdWJsaXNoZXIy MjY2OTA4MA==